{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T08:13:34Z","timestamp":1789546414973,"version":"build-2803163510"},"reference-count":23,"publisher":"Wiley","issue":"18","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["acsjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Cancer"],"published-print":{"date-parts":[[2026,9,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Covalent BTK inhibitors (cBTKis) are the cornerstone of chronic lymphocytic leukemia (CLL)\/small lymphocytic leukemia (SLL) therapy, yet real\u2010world data on dose modifications and their differential impact on long\u2010term outcomes remain incompletely defined. This study investigated the incidence, timing, and the effectiveness of drug switching in a real\u2010world CLL cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this 7\u2010year retrospective real\u2010world study, 324 CLL\/SLL patients treated at a specialized Shanghai outpatient clinic (April 2018\u2013April 2025; median follow\u2010up, 42 months) were analyzed. Dose modifications were classified as dose interruption (DI) or dose reduction (DR). Their prognostic impact on progression\u2010free (PFS) and overall survival (OS) was assessed by Kaplan\u2013Meier analysis and multivariate Cox regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The 42\u2010month PFS rate was 70.2%. Of 324 patients, 229 (70.7%) experienced dose reductions or interruptions; infections were the predominant cause (61.9%). The full\u2010dose (FD) group (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a090) demonstrated superior 4\u2010year PFS (93% vs. 58%,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0&lt;\u00a0.001) and OS (98% vs. 76%,\n                      <jats:italic>p<\/jats:italic>\n                      =\u00a0.007). Early modifications (0\u20133 months) were independent predictors of inferior PFS (hazard ratio [HR], 3.93,\n                      <jats:italic>p<\/jats:italic>\n                      =\u00a0.008) and OS (HR,\u00a03.29,\n                      <jats:italic>p<\/jats:italic>\n                      =\u00a0.014). Prolonged DI (&gt;14 days) was associated with inferior PFS (HR,\u00a02.64) and OS (HR,\u00a02.15), whereas DR and short DI (\u226414 days) had negligible impact. Early (0\u20133 months) prolonged DI was devastating\u00a0(3\u2010year PFS, 41.2%; HR,\u00a03.84,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0&lt;\u00a0.001). cBTKi switching (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a082; 100% nonprogression\u2010driven) shortened DI (median, 6 vs. 14 days) and was independently associated with superior OS (HR,\u00a00.34,\n                      <jats:italic>p<\/jats:italic>\n                      =\u00a0.018) and PFS (HR,\u00a00.36,\n                      <jats:italic>p<\/jats:italic>\n                      =\u00a0.022).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Early prolonged DI is the dominant adverse prognostic factor in cBTKi\u2010treated CLL\/SLL. Proactive switching minimizes treatment gaps and improves survival, supporting a timing\u2010aware, DI\u2010 versus DR\u2010informed approach to dose management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/cncr.70578","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T08:30:15Z","timestamp":1789461015000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Timing matters: Impact of covalent BTK inhibitor dose modifications on outcomes in chronic lymphocytic leukemia\/small lymphocytic leukemia\u2014A 7\u2010year real\u2010world study"],"prefix":"10.1002","volume":"132","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2575-4277","authenticated-orcid":false,"given":"Jiaojiao","family":"Zhang","sequence":"first","affiliation":[{"name":"State Key Laboratory of Medical Genomics Shanghai Institute of Hematology National Research Center for Translational Medicine at Shanghai Ruijin Hospital Shanghai Jiao Tong University School of Medicine  Shanghai China"},{"name":"Shanghai Key Laboratory of Gene Editing and Cell\u2010based Immunotherapy for Hematological Diseases Ruijin Hospital Shanghai Jiao Tong University School of Medicine  Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Luo","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Medical Genomics Shanghai Institute of Hematology National Research Center for Translational Medicine at Shanghai Ruijin Hospital Shanghai Jiao Tong University School of Medicine  Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaozhong","family":"Shen","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Medical Genomics Shanghai Institute of Hematology National Research Center for Translational Medicine at Shanghai Ruijin Hospital Shanghai Jiao Tong University School of Medicine  Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Ren","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Medical Genomics Shanghai Institute of Hematology National Research Center for Translational Medicine at Shanghai Ruijin Hospital Shanghai Jiao Tong University School of Medicine  Shanghai China"},{"name":"Shanghai Key Laboratory of Gene Editing and Cell\u2010based Immunotherapy for Hematological Diseases Ruijin Hospital Shanghai Jiao Tong University School of Medicine  Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyang","family":"Liu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Medical Genomics Shanghai Institute of Hematology National Research Center for Translational Medicine at Shanghai Ruijin Hospital Shanghai Jiao Tong University School of Medicine  Shanghai China"},{"name":"Shanghai Key Laboratory of Gene Editing and Cell\u2010based Immunotherapy for Hematological Diseases Ruijin Hospital Shanghai Jiao Tong University School of Medicine  Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Chen","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Medical Genomics Shanghai Institute of Hematology National Research Center for Translational Medicine at Shanghai Ruijin Hospital Shanghai Jiao Tong University School of Medicine  Shanghai China"},{"name":"Shanghai Key Laboratory of Gene Editing and Cell\u2010based Immunotherapy for Hematological Diseases Ruijin Hospital Shanghai Jiao Tong University School of Medicine  Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Jiang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Medical Genomics Shanghai Institute of Hematology National Research Center for Translational Medicine at Shanghai Ruijin Hospital Shanghai Jiao Tong University School of Medicine  Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangqin","family":"Weng","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Medical Genomics Shanghai Institute of Hematology National Research Center for Translational Medicine at Shanghai Ruijin Hospital Shanghai Jiao Tong University School of Medicine  Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Wang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Medical Genomics Shanghai Institute of Hematology National Research Center for Translational Medicine at Shanghai Ruijin Hospital Shanghai Jiao Tong University School of Medicine  Shanghai China"},{"name":"Shanghai Key Laboratory of Gene Editing and Cell\u2010based Immunotherapy for Hematological Diseases Ruijin Hospital Shanghai Jiao Tong University School of Medicine  Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian\u2010Qing","family":"Mi","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Medical Genomics Shanghai Institute of Hematology National Research Center for Translational Medicine at Shanghai Ruijin Hospital Shanghai Jiao Tong University School of Medicine  Shanghai China"},{"name":"Shanghai Key Laboratory of Gene Editing and Cell\u2010based Immunotherapy for Hematological Diseases Ruijin Hospital Shanghai Jiao Tong University School of Medicine  Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2025032468"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024024476"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO\u201024\u201002265"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024028205"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26826"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1184395"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27519"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045\u2010020\u201000870\u2010w"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.2998"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers18061000"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102017\u201009\u2010806398"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2026.2637862"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/hem3.70403"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2021.280376"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2024.1408983"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021012315"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102025\u20103301"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737140.2024.2398483"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2211582"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.16_suppl.7036"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1158\/2643\u20103230.BCD\u201025\u20100345"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102024\u2010199676"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2504341"}],"container-title":["Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cncr.70578","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/cncr.70578","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cncr.70578","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T07:40:59Z","timestamp":1789544459000},"score":1,"resource":{"primary":{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/10.1002\/cncr.70578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":23,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2026,9,15]]}},"alternative-id":["10.1002\/cncr.70578"],"URL":"https:\/\/doi.org\/10.1002\/cncr.70578","archive":["Portico"],"relation":{},"ISSN":["0008-543X","1097-0142"],"issn-type":[{"value":"0008-543X","type":"print"},{"value":"1097-0142","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]},"assertion":[{"value":"2026-04-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70578"}}